Melphalan, Antimelanoma Immunity, and Inflammation--Letter

Cancer Res. 2015 Dec 15;75(24):5398-9. doi: 10.1158/0008-5472.CAN-15-1184. Epub 2015 Dec 1.

Authors

Anna Martner¹, Junko Johansson¹, Ilan Ben-Shabat², Roger Olofsson Bagge³

Affiliations

¹ Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
² Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
³ Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. [email protected].

PMID: 26627012
DOI: 10.1158/0008-5472.CAN-15-1184

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Antigens, Surface / physiology*
Antineoplastic Agents, Alkylating / pharmacology*
Calreticulin / physiology*
Humans
Melanoma / immunology*
Melphalan / pharmacology*
Skin Neoplasms / immunology*

Substances

Antigens, Surface
Antineoplastic Agents, Alkylating
Calreticulin
Melphalan